Henan Pediatric Clinical Research Center and Henan Key Laboratory of Child Brain Injury, Third Affiliated Hospital and Institute of Neuroscience, Zhengzhou University, Zhengzhou, 450052, China.
Department of Neonatology, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Inflamm Res. 2023 Apr;72(4):757-768. doi: 10.1007/s00011-023-01702-6. Epub 2023 Feb 18.
This study aimed to explore potential inflammatory biomarkers for early prediction of necrotizing enterocolitis (NEC) in premature infants.
Plasma samples were collected from premature infants with NEC (n = 30), sepsis (n = 29), and controls without infection (n = 29). The 92 inflammatory-related proteins were assessed via high-throughput OLINK proteomics platform.
There were 11 inflammatory proteins that significate differences (p < 0.05) among NEC, sepsis and control preterm infants, which include IL-8, TRAIL, IL-24, MMP-10, CCL20, CXCL1, OPG, TSLP, MCP-4, TNFSF14 and LIF. A combination of these 11 proteins could serve as differential diagnosis between NEC and control infants (AUC = 0.972), or between NEC and sepsis infants (AUC = 0.881). Furthermore, the combination of IL-8, OPG, MCP-4, IL-24, LIF and CCL20 could distinguish Stage II and III of NEC (AUC = 0.977). Further analysis showed the combination of IL-8, IL-24 and CCL20 have the best prediction value for NEC and control (AUC = 0.947), NEC and sepsis (AUC = 0.838) and different severity of NEC (AUC = 0.842).
Inflammatory proteins were different expressed in premature infants with NEC compared with controls or sepsis. Combining these proteins provide a higher diagnostic potential for preterm NEC infants.
本研究旨在探索潜在的炎症生物标志物,用于早期预测早产儿坏死性小肠结肠炎(NEC)。
收集 NEC(n=30)、败血症(n=29)和无感染对照早产儿(n=29)的血浆样本。通过高通量 OLINK 蛋白质组学平台评估 92 种炎症相关蛋白。
NEC、败血症和对照组早产儿之间有 11 种炎症蛋白存在显著差异(p<0.05),包括白细胞介素-8(IL-8)、肿瘤坏死因子相关凋亡诱导配体(TRAIL)、白细胞介素-24(IL-24)、基质金属蛋白酶-10(MMP-10)、C 趋化因子配体 20(CCL20)、C 型趋化因子配体 1(CXCL1)、骨保护素(OPG)、胸腺基质淋巴细胞生成素(TSLP)、单核细胞趋化蛋白-4(MCP-4)、肿瘤坏死因子超家族成员 14(TNFSF14)和白血病抑制因子(LIF)。这 11 种蛋白的组合可用于 NEC 与对照组婴儿的鉴别诊断(AUC=0.972),或用于 NEC 与败血症婴儿的鉴别诊断(AUC=0.881)。此外,IL-8、OPG、MCP-4、IL-24、LIF 和 CCL20 的组合可区分 NEC Ⅱ期和Ⅲ期(AUC=0.977)。进一步分析显示,IL-8、IL-24 和 CCL20 的组合对 NEC 与对照组(AUC=0.947)、NEC 与败血症(AUC=0.838)和不同严重程度的 NEC(AUC=0.842)具有最佳的预测价值。
与对照组或败血症相比,NEC 早产儿的炎症蛋白表达不同。联合这些蛋白可为早产儿 NEC 提供更高的诊断潜力。